Skip to main content
. 2001 Jan;75(2):750–758. doi: 10.1128/JVI.75.2.750-758.2001

TABLE 1.

Microarray analysis of IFN-treated and HSV-1-infected HEL cells

Accession no. Gene or gene product and description Relative change in level of expression
KOS
UV-treated KOS
KM110
IFN-α
Set A Set B Set A Set B Set A Set B Set A Set B
AA193601 MX1, myxovirus (influenza virus) resistance 1, homolog of murine (IFN-inducible protein p78) 20.06 7.68 10.08 7.40 16.55 7.44
R82716 ISG15, IFN-stimulated protein, 15 kDa 18.33 16.53 20.46 11.83 16.55 13.88
N63988 EST 13.69 9.1 6.25 6.21
W52254 IFIT1, IFN-induced protein 56 9.83 12.05 4.93 7.72 6.16 4.57
AA152305 SCYB10, small inducible cytokine subfamily B (Cys-X-Cys), member 10 7.63 2.81 2.42 2.58
W49782 MX1, myxovirus (influenza virus) resistance 1, homolog of murine (IFN-inducible protein p78) 6.45 4.59 3.78 3.55 a 5.17
AA035361 STAT1, signal transducer and activator of transcription 1, 91 kDa 6.33 4.13 3.94 3.48 4.37 3.08
T95113 Homo sapiens cig5 mRNA, partial sequence 5.57 2.18 4 1.61 2.01 1.4
R76719 EST, weakly similar to GEF-2 protein (H. sapiens) 5.38 4.76 6.53 4.27 8.2 6.78
R09187 EST 5.18 2.63 4.87 1.82 2.6 2.29
AA035024 MX2, myxovirus (influenza virus) resistance 2, homolog of murine 4.68 2.03 2.9 1.92
T92814 EST, homolog to H. sapiens cig41 4.5 2.91 3.41 3.07 2.54 2.28
H49854 IFITM1, IFN-induced transmembrane protein 1 (9–27) 4.43 4.49 5.69 4.41 6.69 5.38
AA046075 EST 3.9 2.91 2.38 1.92 2.33 2.15
R59506 EST, homologue to H. sapiens cyclin-E binding protein 3.85 2.13 2.92 1.64
AA043535 IMAGE-487558 3.31 1.98 2.34 2.14 2.46 2.15
W47619 OAS3, 2′→5′ oligoadenylate synthetase 3 2.99 2.13 2.73 2.26 2.13 2.46
N63887 EST, weakly similar to TYKi protein (Mus musculus) 2.81 1.75 2.21 1.67
N43008 SP100, nuclear antigen Sp100 2.81 1.91 2.23 1.77 2.38 2.38
T74462 ABCB2, ATP-binding cassette, subfamily B (MDR/TAP), member 2 2.77 2.03 2.44 1.4 2.21 1.67
R34567 OAS2, 2′→5′ oligoadenylate synthetase 2 2.59 1.93 2.3 1.71 2.21 2.45
H70440 GS3686, hypothetical protein, expressed in osteoblast 2.48 2.06 3.29 1.41 2.28 1.95
T86070 EST 2.42 1.88 2.08 1.66
R23341 B2M, β-2-microglobulin 2.3 1.91 3.09 1.94 2.83 2.29
W94862 ADAR, adenosine deaminase, RNA specific 2.29 1.94 2 1.95
AA028065 BRF2, butyrate response factor 2 (EGF-response factor 2) 2.25 1.93
W47350 RARRES3, retinoic acid receptor responder (tazarotene induced) 3 2.13 1.97 2.03 1.95
T80567 KIAA072, KIAA0725 protein 2.02 1.74 2.31 1.5
AA001748 EST, weakly similar to angiopoietin Y1 (H. sapiens) 2.01 2.35
AA040506 IMAGE-485950 2 1.75
AA040032 KIAA0015, KIAA0015 gene product 0.55 0.36 1.99 2.37 2.04 2.18 3.37 3.59
W63787 PHGDH, β-phosphoglycerate dehydrogenase 0.42 0.5
R13977 EST 0.37 0.43 0.52 0.47
R80595 SOD2, superoxide dismutase 2, mitochondrial 3.7 1.81
H60340 IMAGE-207631 1.78 2.08
H17813 TOP2A, topoisomerase II alpha 0.48 0.48
R40483 Homo sapiens clone 24877 mRNA sequence 3.31 1.85
N34456 NT5, 5′ nucleotidase (CD73) 2.19 1.83
AA040062 EST, weakly similar to yeast antiviral protein SK12 and ATP-dependent DNA helicase 3.65 1.48 2.84 2.14 2 1.59
N58703 IMAGE-247579 2.1 1.51 2.15 1.89
W88741 EST 5.41 44.08
N30287 EST, weakly similar to Wiscott-Aldrich syndrome protein homolog 2.32 2.58
W67568 HLA-A, MHC class I, A 0.43 0.18 2.64 3.21
AA053162 HLA-B, MHC class I, B 2.42 2.32
W00378 HLA-C, MHC class I, C 2.22 2.43
a

—, Intensity of the spot on the array was below local background.